489
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Quantitative and Qualitative Exploration of Meaningful Change on the Vineland Adaptive Behavior Scales (Vineland™-II) in Children and Adolescents with Autism Without Intellectual Disability Following Participation in a Clinical Trial

ORCID Icon, , , , , & show all
Pages 337-354 | Received 21 Jan 2023, Accepted 19 Oct 2023, Published online: 20 Nov 2023

References

  • Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508–520. doi:10.1016/S0140-6736(18)31129-2
  • Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183–1215. doi:10.1542/peds.2007-2361
  • Brugha TS, McManus S, Bankart J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2011;68(5):459–465. doi:10.1001/archgenpsychiatry.2011.38
  • Sun X, Allison C, Wei L, et al. Autism prevalence in China is comparable to Western prevalence. Mol Autism. 2019;10(1):1–19. doi:10.1186/s13229-018-0246-0
  • Chatham C, Taylor K, Charman T, et al. Adaptive behavior in autism: minimal clinically important differences on the Vineland-II. Autism Res. 2018;11(2):270–283. doi:10.1002/aur.1874
  • Sparrow S, Cicchetti D, Balla D. Vineland Adaptive Behavior Scales. Third ed. San Antonio: TX Pearson; 2016.
  • Willgoss T, Le Scouiller S, Squassante L, et al. Psychometric Properties of a Novel Vineland-II 2-Domain Composite Score to Assess Social Communication and Social Interaction in ASD. Published in the October 2018 Scientific Proceedings supplement issue of the Journal of the American Academy of Child and Adolescent Psychiatry. Vol. 57; 2018:S231–232.
  • Hollander E, Jacob S, Jou R, et al. Balovaptan vs Placebo for social communication in childhood Autism spectrum disorder: a randomized clinical trial. JAMA Psychiatry. 2022. 79(8):760–9
  • Operto FF, Smirni D, Scuoppo C, et al. Neuropsychological profile, emotional/behavioral problems, and parental stress in children with neurodevelopmental disorders. Brain Sci. 2021;11(5):584. doi:10.3390/brainsci11050584
  • Operto FF, Pastorino GMG, Scuoppo C, et al. Adaptive behavior, emotional/behavioral problems and parental stress in children with autism spectrum disorder. Front Neurosci. 2021;15:751465. doi:10.3389/fnins.2021.751465
  • Kanne SM, Gerber AJ, Quirmbach LM, Sparrow SS, Cicchetti DV, Saulnier CA. The role of adaptive behavior in autism spectrum disorders: implications for functional outcome. J Autism Dev Disord. 2011;41(8):1007–1018. doi:10.1007/s10803-010-1126-4
  • Kuhlthau K, Payakachat N, Delahaye J, et al. Quality of life for parents of children with autism spectrum disorders. Res Autism Spectr Disord. 2014;8(10):1339–1350. doi:10.1016/j.rasd.2014.07.002
  • Sparrow SS, Cicchetti DV, Balla DA. Vineland Adaptive Behavior Scales Vineland-II: Survey Forms Manual. Pearson Minneapolis, MN; 2005.
  • Qin S, Nelson L, McLeod L, Eremenco S, Coons SJ. Assessing test–retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula. Qual Life Res. 2019;28(4):1029–1033. doi:10.1007/s11136-018-2076-0
  • Cappelleri JC, Bushmakin AG. Interpretation of patient-reported outcomes. Stat Methods Med Res. 2014;23(5):460–483. doi:10.1177/0962280213476377
  • Lecavalier L, Leone S, Wiltz J. The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. J Intellect Disabil Res. 2006;50(3):172–183. doi:10.1111/j.1365-2788.2005.00732.x
  • Coon CD, Cappelleri JC. Interpreting change in scores on patient-reported outcome instruments. Ther Innov Regul Sci. 2016;50(1):22–29. doi:10.1177/2168479015622667
  • Coon CD, Cook KF. Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores. Qual Life Res. 2018;27(1):33–40. doi:10.1007/s11136-017-1616-3
  • Regnault A, Willgoss T, Barbic S; On behalf of the International Society for Quality of Life Research Mixed Methods Special Interest G.Towards the use of mixed methods inquiry as best practice in health outcomes research. J Patient-Rep. 2018;2(1):19. doi:10.1186/s41687-018-0043-8
  • Staunton H, Willgoss T, Nelsen L, et al. An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments. J Patient-Rep. 2019;3(1):1–10. doi:10.1186/s41687-019-0100-y
  • Sparrow S, Cicchetti D, Balla D. Vineland Adaptive Behavior Scales—2nd Edition Manual. Minneapolis, MN: NCS Pearson Inc.; 2005.
  • Willgoss T, Le Scouiller S, Squassante L, et al. Psychometric properties of a novel vineland-II 2-domain composite score to assess social communication and social interaction in ASD (vol 57, pg S231, 2018). J Am Acad Child Adolesc Psychiatry. 2020;59(2):330.
  • Bolognani F, Del Valle Rubido M, Squassante L, et al. A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder. Sci Transl Med. 2019;11(491):eaat7838. doi:10.1126/scitranslmed.aat7838
  • Busner J, Miller DS, Targum SD. A survey of investigator beliefs about including adverse events and comorbidity fluctuations in CNS CGI ratings. Pharmacopsychiatry. 2007;25:171–176.
  • Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service; 1976.
  • Butter E, Mulick J. The Ohio autism clinical impressions scale (OACIS). Columbus, OH: Children’s Research Institute; 2006.
  • Cappelleri JC, Deal LS, Petrie CD. Reflections on ISPOR’s clinician-reported outcomes good measurement practice recommendations. Value Health. 2017;20(1):15–17. doi:10.1016/j.jval.2016.12.007
  • Hemphill JF. Interpreting the magnitudes of correlation coefficients. Am Psychol. 2003;58(1):78–79. doi:10.1037/0003-066X.58.1.78
  • Armijo-Olivo S, Warren S, Fuentes J, Magee DJ. Clinical relevance vs. statistical significance: using neck outcomes in patients with temporomandibular disorders as an example. Man Ther. 2011;16(6):563–572. doi:10.1016/j.math.2011.05.006
  • Hudgens S, Floden L, Blackowicz M, et al. Meaningful change in depression symptoms assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) among patients with treatment resistant depression in two, randomized, double-blind, active-controlled trials of esketamine nasal spray combined with a new oral antidepressant. J Affect Disord. 2021;281:767–775. doi:10.1016/j.jad.2020.11.066
  • Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861–873. doi:10.1016/S0895-4356(99)00071-2
  • Donoghue D, Stokes EK. How much change is true change? The minimum detectable change of the Berg Balance Scale in elderly people. J Rehabil Med. 2009;41(5):343–346. doi:10.2340/16501977-0337
  • McDowell I. Measuring Health: A Guide to Rating Scales and Questionnaires. USA: Oxford University Press; 2006.
  • Lai M-C, Baron-Cohen S, Buxbaum JD. Understanding autism in the light of sex/gender. Mol Autism. 2015;6(1):1–5. doi:10.1186/s13229-015-0021-4